George Karpouzas, MD, on How bDMARDS Prevent CV Events in Patients With RA
In this podcast, George Karpouzas, MD, talks about his study that\xa0evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as their mechanism of action. More at: www.consultant360.com/rheumatology.